source
- FDA gene and cell therapy review office loses acting director Vijay KumarVijay Kumar has announced he will step down from his role as acting director of the Office of Gene and Cell Therapy Reviews within the FDA's Center for Biologics Evaluation and Research. Karim Mik…
- Investors increase stakes in Bain-backed biotech startup as FDA gene‑therapy chief departsInvestors are putting more money into a biotech startup backed by private‑equity firm Bain Capital, according to the STAT+ newsletter. Vijay Kumar is leaving his role as acting director of the FDA…